How to deal with regression to the mean in intervention studies

Lancet

Volumn 347, Issue 8996, 1996, Pages 241-243

  Yudkin, P L ^a,b   Stratton, I M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; DIET; INTERMETHOD COMPARISON; LIFESTYLE; MEASUREMENT; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; SHORT SURVEY; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS;

EID: 0030041585     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90410-9     Document Type: Article

References (22)

1. Johnston HJ, Jones M, Ridler-Dutton G, Spechler F, Stokes GS, Wyndham LE. Diet modification in lowering plasma cholesterol levels. Med J Aust 1995; 162: 524-26.
2. Bland JM, Altman DG. Some examples of regression towards the mean. BMJ 1994; 309: 780.
3. Gardner MJ, Heady JA. Some effects of within-person variability in epidemiologic studies. J Chron Dis 1973; 26: 781-95.
4. James KE. Regression towards the mean in uncontrolled clinical studies. Biometrics 1973; 29: 121-30.
5. Shepard DS, Finison L. Blood pressure reductions: correcting for regression to the mean. Prev Med 1983; 12: 304-17.
6. Newell D, Simpson J. Regression to the mean. Med J Aust 1990; 153: 166-68.
7. Johnson WD, George VT. Effect of regression to the mean in the presence of within-subject variability. Stats Med 1991; 10: 1295-302.
8. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS) VIII: study design, progress and performance. Diabetologia 1991; 34: 877-902.
9. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976; 104: 493-98.
10. Thompson SG, Pocock SJ. The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol 1990; 43: 783-89.
11. Smith SJ, Cooper GR, Myers GL, Sampson EJ. Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem 1993; 39: 1012-22.
12. Ederer F. Serum cholesterol: effects of diet and regression towards the mean. J Chron Dis 1972; 25: 277-89.
13. Senn SJ, Brown RA. Estimating treatment effects in clinical trials subject to regression to the mean. Biometrics 1985; 41: 555-60.
14. Armitage P, Berry G. Statistical methods in medical research, 2nd ed. Oxford, Blackwell Scientific, 1987: 152.
15. SAS Institute Inc SAS language: reference, version 6, 1st ed. Cary, NC: SAS Institute, 1990: 1042.
16. Klepp K-I, Ulvik RJ, Matthiesen SB, Hannan P, Jacobs DR, Aaro LE. Cholesterol screening: observed cholesterol reduction in a prospective study in Norway. Eur J Publ Hlth 1993; 3: 38-42.
17. Hannan PJ, Jacobs DR, McGovern P, Klepp K-I, Elmer P. Estimating the effect of regression to the mean under stochastic censoring. Am J Epidemiol 1994; 139: 422-31.
18. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Lancet 1981; ii: 1303-10.
19. Rose G, Heller RF, Tunstall Pedoe H, Christie DGS. Heart disease prevention project: a randomised controlled trial in industry. BMJ 1980; i: 747-51.
20. Medical Research Council Working Party. MRC trial of treatment of mild hypertension. BMJ 1985; 291: 97-104.
21. Denke MA, Frantz ID. Response to a cholesterol-lowering diet: efficacy is greater in hyper-cholesterolemic subjects even after adjustment for regression to the mean. Am J Med 1993; 94: 637-31.
22. Senn SJ. How much of the placebo 'effect' is really statistical regression? Stats Med 1988; 7: 1203.